• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

March 22, 2017

New Research Seeks to Uncover Link Between Vascular Disease, Dementia

Author(s):

Laurie Toich, Assistant Editor

The MarkVID consortium will explore biomarkers that could treat small vessel cognitive impairment and dementia.

The National Institutes of Health (NIH) recently launched MarkVCID, a consortium to study small vessel diseases of the brain, and how they may be linked to vascular contributions to cognitive impairment and dementia (VCID).

The MarkVID 5-year program was developed to improve current biomarkers used for small vessel VCID, and discover novel biomarkers that may lead to effective treatments. This project is a collaboration between the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), and 7 research teams, according to a press release.

“We have brought together a number of outstanding research groups to further develop and validate candidate biomarkers for cerebral small vessel disease,” said Steven M. Greenberg, MD, PhD, project leader for the MarkVCID Coordinating Center. “This will be achieved by identifying and focusing on the most promising biomarkers across the research sites.”

VCID affects millions of Americans, with some developing Alzheimer’s disease and related conditions. Since small vessel VCID worsens over time, early treatment is crucial. However, the changes can be difficult to detect, especially during early stages when intervention would be the most successful, according to the NIH.

Individual research teams are currently using multiple biomarker candidates derived from MRI scans, fluid analysis, and other physiological measurements to determine disease progression. The goal of the new consortium is to validate candidate biomarkers so they can be advanced to clinical trials and eventually used in clinical settings, the NIH reported.

In the second phase of the project, the teams will communicate their findings to better determine the most successful and promising biomarkers. This phase is expected to start in 2 years.

Included in the consortium will be teams of investigators from the University of California, Johns Hopkins University, the University of New Mexico Health Sciences Center, Rush University Medical Center, Boston University Medical Campus, the University of Southern California, and the University of Kentucky.

“The team-based approach taken by the consortium allows us to study candidate biomarkers across different clinical settings at multiple institutions,” said Roderick Corriveau, PhD, program director, NINDS. “Ultimately, we hope to develop a gold standard to identify cerebral small vessel disease early enough to intervene with treatment.”

Related Videos
1 expert is featured in this series.
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Health care professional about to conduct a pap smear -- Image credit: Rabizo Anatolii | stock.adobe.com
May 9th 2025

FDA Approves Teal Wand, First At-Home Self-Collection Cervical Cancer Screening Device

Gillian McGovern, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer
May 9th 2025

Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer

Benjamin Gibson, PharmD, PAHM
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Woman experiencing pain from endometriosis -- Image credit: Khunatorn | stock.adobe.com
May 9th 2025

Study Finds Endometriosis May Be Linked to Traumatic Experiences

Gillian McGovern, Associate Editor
Atherosclerosis Animation: Cholesterol Plaque Formation, Rupture, and Blood Clot in Artery
May 9th 2025

Plozasiran Shows Promise as Cholesterol-Lowering Treatment for Mixed Hyperlipidemia

Luke Halpern, Assistant Editor
Related Content
Advertisement
Health care professional about to conduct a pap smear -- Image credit: Rabizo Anatolii | stock.adobe.com
May 9th 2025

FDA Approves Teal Wand, First At-Home Self-Collection Cervical Cancer Screening Device

Gillian McGovern, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer
May 9th 2025

Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer

Benjamin Gibson, PharmD, PAHM
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Woman experiencing pain from endometriosis -- Image credit: Khunatorn | stock.adobe.com
May 9th 2025

Study Finds Endometriosis May Be Linked to Traumatic Experiences

Gillian McGovern, Associate Editor
Atherosclerosis Animation: Cholesterol Plaque Formation, Rupture, and Blood Clot in Artery
May 9th 2025

Plozasiran Shows Promise as Cholesterol-Lowering Treatment for Mixed Hyperlipidemia

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.